Older adults' perceptions and understanding of direct-to-consumer advertising

Journal of Consumer Marketing

Volumn 23, Issue 1, 2006, Pages 6-14

  Jones, Sandra C ^a,b   Mullan, Judy ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Graduate School of Public Health   (Australia)

Author keywords

Advertising; Elderly people; Pharmaceutical products

Indexed keywords

EID: 33644557431     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760610641118     Document Type: Article

References (41)

1. Avorn, J. (2003), "Advertising and prescription drugs: promotion, advertising, and the public's health", Health Affairs, February, pp. 104-8.
2. Bell, R.A., Wilkes, M.S. and Kravitz, R.L. (2000), "The educational value of consumer-targeted prescription drug print advertising", Journal of Family Practice, Vol. 49 No. 12, pp. 1092-8.
3. Bittar, C. (2004), "Take as directed", Brandweek, Vol. 45, pp. 24-8.
4. Dal-Pizzol, F. (2002), "Drug advertisements in less-developed countries", The Lancet, Vol. 359 No. 9315, pp. 1439-40.
5. Deshpandé, A., Menon, A. and Perri, M. (2004), "Direct-to-consumer advertising and its utility in health care decision making: a consumer perspective", Journal of Health Communication, Vol. 9, pp. 499-513.
6. Donovan, J. (1999), "Advertising pharmaceuticals to Australians", Australian Prescriber, Vol. 22, pp. 74-5.
7. Frank, R.G., Berndt, E.R., Donohue, J.M., Epstein, A.M. and Rosenthal, M.B. (2002), Trends in Direct-to-consumer Advertising of Prescription Drugs, Kaiser Family Foundation, Menlo Park, CA, pp. 1-14.
8. Frieden, J. (2003), "Value of direct-to-consumer ads questioned: education vs increased costs", Skin & Allergy News, Vol. 34 No. 9, pp. 10-12.
9. Gold, J.L. (2003), "Paternalistic or protective? Freedom of expression and direct-to-consumer drug advertising policy in Canada", Health Law Review, Vol. 11 No. 2, pp. 30-8.
10. Good, B. (2003), "The drug trade (success of pharmaceutical industry's to-consumer advertising)", Men's Health, Vol. 18 No. 7, p. 34.
11. Handlin, A., Mosca, J.B., Forgione, D.A. and Pitta, D. (2003), "DTC pharmaceutical advertising: the debate's not over", Journal of Consumer Marketing, Vol. 20 No. 3, pp. 227-37.
12. Heinrich, J. (2002), "Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations", US General Accounting Office, pp. 1-53.
13. Hoek, J. and Gendall, P. (2002), "Direct-to-consumer advertising down under: an alternative perspective and regulatory framework", Journal of Public Policy & Marketing, Vol. 21 No. 2, pp. 202-12.
14. Hoek, J., Gendall, P. and Calfee, J. (2004), "Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses", International Journal of Advertising, Vol. 23 No. 2, pp. 197-228.
15. Homer, A. (1999), "Direct-to-consumer prescription drug advertising builds bridges between patients and physicians", Journal of the American Medical Association, Vol. 281, pp. 380-2.
16. Kaiser Family Foundation (2003), Impact of Direct-to-consumer Advertising on Prescription Drug Spending, The Henry J. Kaiser Foundation, Washington, DC, pp. 1-8.
17. Kaphingst, K.A. and DeJong, W. (2004), "The educational potential of direct-to-consumer prescription drug advertising", Health Affairs, Vol. 23 No. 4, pp. 143-50.
18. (The) Lancet (2002), "Europe on the brink of direct-to-consumer advertising", The Lancet, Vol. 359 No. 9319, p. 1709.
19. Lewis, C. (2003), "The impact of direct-to-consumer advertising", US Food and Drug Administration Consumer Magazine, pp. 1-2.
20. Lexchin, J. and Mintzes, B. (2002), "Direct-to-consumer advertising of prescription drugs: the evidence says 'no'", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 194-201.
21. Mehta, A. and Purvis, S.C. (2003), "Consumer response to print prescription drug advertising", Journal of Advertising Research, Vol. 43 No. 2, pp. 194-206.
22. Miller, K. and Waller, D. (2004), "Attitudes towards DTC advertising in Australia: an exploratory study", International Journal of Advertising, Vol. 23, pp. 389-405.
23. Mintzes, B. (2002), "Direct-to-consumer prescription drug advertising: is there evidence of health benefits?", Essential Drugs Monitor, Vol. 31, pp. 16-19.
24. Mintzes, B., Barer, M.L., Kazanjian, A., Bassett, K., Evans, R.G. and Morgan, S. (2002a), "An assessment of the health system impacts of direct-to-consumer advertising of prescription medicines (DTCA)", Health Policy Research Unit Reports, The University of British Columbia, Vancouver, pp. 1-7.
25. Mintzes, B., Barer, M.L., Kravitz, R.L., Bassett, K., Lexchin, J., Kazanjian, A., Evans, R.G., Pan, R. and Marion, S.A. (2003), "How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA", Canadian Medical association Journal, Vol. 169 No. 5, pp. 405-18.
26. Mintzes, B., Barer, M.L., Kravitz, R.L., Kazanjian, A., Bassett, K., Lexchin, J., Evans, R.G., Pan, R. and Marion, S.A. (2002b), "Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey", British Medical Journal, Vol. 324, pp. 278-9.
27. Murray, E. (2002), "Direct-to-patient drug advertising criticised", GP, July, p. 10.
28. Murray, E., Lo, B., Pollack, L., Donelan, K. and Lee, K. (2003), "Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship", Journal of the American Board of Family Practice, Vol. 16, pp. 513-24.
29. Newby, D.A. and Henry, D.A. (2002), "Drug advertising: truths, half truths and few statistics", Medical Journal of Australia, Vol. 177 No. 6, pp. 285-6.
30. Parker, R.S. and Pettijohn, C.E. (2003), "Ethical considerations in the use of direct-to-consumer advertising and pharmaceutical promotions: the impact on pharmaceutical sales and physicians", Journal of Business Ethics, Vol. 48, pp. 279-90.
31. Roberts, S. (2003), "Drug ads: some mislead consumers", Diabetes Forecast, Vol. 56 No. 10, pp. 46-9.
32. Robinson, A.R., Hohmann, K.B., Rifkin, J.I., Topp, D., Gilroy, C.M., Pickard, J.A. and Anderson, R.J. (2004), "Direct-to-consumer pharmaceutical advertising", Archives of Internal Medicine, Vol. 164, pp. 427-32.
33. Rosenthal, M.B. and Kaiser, H.J. (2003), "Impact of direct-to-consumer advertising on prescription drug spending", Medical Benefits, Vol. 20 No. 16, p. 9.
34. Rosenthal, M.B., Berndt, E.R., Donohue, J.M., Epstein, A.M. and Frank, R.G. (2003), Demand Effects of Recent Changes in Prescription Drug Promotion, Kaiser Family Foundation, Menlo Park, CA, pp. 1-33.
35. Roth, M.S. (1996), "Patterns in direct-to-consumer prescription drug print advertising and their public policy implications", Journal of Public Policy and Marketing, Vol. 15, pp. 63-75.
36. SCRIP World Pharmaceutical News (2003), "US DTC advertising declines for first time", SCRIP World Pharmaceutical News, No. 2883.
37. Spurgeon, D. (2003), "'Direct to consumer' advertising of drugs in Canada could add £550m to healthcare costs", British Medical Journal, Vol. 327 No. 7415, p. 582b.
38. Tosh, M. (2004), "DTC advertising gets the green light", Medical Marketing and Media, Vol. 39 No. 4, pp. 36-40.
39. Watson, R. (2002), "MEPs reject US-style direct advertising of drugs", British Medical Journal, Vol. 325 No. 7371, p. 990.
40. Watson, R. (2003), "EU health ministers reject proposal for limited direct to consumer advertising (news roundup)", British Medical Journal, Vol. 326 No. 7402, p. 1284.
41. Woloshin, S., Schwartz, L.M., Tremmel, J. and Welch, H.G. (2001), "Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?", The Lancet, Vol. 358 No. 9288, pp. 1141-6.